RA Capital represented The Steritech Group, Inc. as exclusive financial advisor in its October 2015 sale to Rentokil Initial plc (LSE:RTO) for $425 million. The acquisition was one of the largest in the pest control industry’s history.
Global reach: RA Capital marketed Steritech to a handful of strategic parties globally. Ultimately, London-based Rentokil was selected, providing complimentary service solutions and a compatible company culture. The transaction strengthens Rentokil’s position as the No. 3 pest control business in the US.
Maximizing value: Steritech was acquired at an EBITA multiple of 42.5x and a revenue multiple of 2.8x, both of which represented a valuation well above historical averages.
Deal execution: RA Capital facilitated a rapid due diligence process that preserved Steritech’s confidentiality and minimized disruptions to the business. This led to the successful close of the deal on October 1, 2015 – less than four months after initiating contact with the interested parties.
About The Steritech Group, Inc.
Steritech, which is headquartered in Charlotte, North Carolina, is a leading provider of pest prevention and brand standards audit services in North America. The company provides a comprehensive suite of ecosensitve pest elimination services and has established itself as a trusted partner to some of the world’s largest and most well-known brands.
About Rentokil Initial plc
Rentokil is one of the largest business services companies in the world providing pest control, hygiene, and workwear services. The company operates in over 60 countries and has annual worldwide revenues of approximately $2.7 billion.